US equities |
NVDA $236.97 ▲+1.29% SPCX $167.21 ▲+5.19% MU $1,068.36 ▼-0.61% TSLA $377.52 ▲+1.87% MSFT $526.57 ▲+1.75% INTC $117.39 ▼-1.63% SNDK $1,732.61 ▲+0.73% META $742.57 ▲+1.99%
FinancialContent

Verve Therapeutics, Inc. - Common Stock (NQ:VERV)

11.13 UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 11.13
Bid (Size) 11.20 (11)
Ask (Size) 11.21 (1)
Prev. Close 11.13
Today's Range 11.13 - 11.13
52wk Range 11.13 - 11.13
Shares Outstanding 61,930,485
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
AI Unlocks Gene-Editing Revolution: $2 Million Grant Propels Disease Cures
A groundbreaking $2 million grant from the National Institutes of Health (NIH) is set to dramatically accelerate advancements in gene-editing technology, with artificial intelligence (AI) emerging as... 
Via TokenRing AI
Topics Artificial Intelligence Climate Change Intellectual Property
News headline image
Generative AI Unleashes a New Era in Genome Editing, Outperforming Nature in Protein Design
London, UK – October 2, 2025 – In a monumental stride for biotechnology and medicine, generative artificial intelligence (AI) has achieved a scientific breakthrough, demonstrating an unprecedented... 
Via TokenRing AI
Topics Artificial Intelligence

Performance

More News

Read More
News headline image
Verve Therapeutics Inc (NASDAQ:VERV): A High-Growth Momentum Stock Aligned with Minervini’s Trend Model ↗
Via Chartmill
News headline image
3 Bullish Biotech Stocks With Explosive Growth Trends ↗
Via MarketBeat
News headline image
Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook ↗
Via MarketBeat
Topics Economy Stocks
News headline image
VERVE THERAPEUTICS INC (NASDAQ:VERV) - A High-Growth Biotech Stock Meeting Minervini's Criteria ↗
Via Chartmill
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week ↗
Via The Motley Fool
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLP, VERV, CVAC on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
VERVE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verve Therapeutics, Inc. - VERV
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst ↗
Via Benzinga
News headline image
This Verve Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday ↗
Via Benzinga
News headline image
Market Monitor News June 18 (Jabil, Reddit & Verve Therapeutics UP - Solar Stocks First Solar, Sunrun & SolarEdge DOWN) ↗
Via Chartmill
News headline image
5 Analysts Assess Verve Therapeutics: What You Need To Know ↗
Via Benzinga
News headline image
These stocks are moving in today's session ↗
Via Chartmill
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, SOAR on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
Which stocks are moving on Tuesday? ↗
Via Chartmill
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
VERV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verve Therapeutics, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Why Verve Therapeutics Stock Is Skyrocketing Today ↗
Via The Motley Fool
News headline image
Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday ↗
Via Benzinga
News headline image
Which stocks are gapping on Tuesday? ↗
Via Chartmill
News headline image
Power Metallic (TSX.V: PNPN) Secures Largest Saudi License Amid June 2025 Gold Surge – Material Gains & More Stocks Inside
Via AB Newswire
News headline image
Verve Therapeutics Stock Rockets 75% Pre-Market After Eli Lilly Agrees To Acquire The Company For Up To $1.3B: Retail Says Offer Is ‘Low’ ↗
Via Stocktwits

Frequently Asked Questions

Is Verve Therapeutics, Inc. - Common Stock publicly traded?
Yes, Verve Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Verve Therapeutics, Inc. - Common Stock trade on?
Verve Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Verve Therapeutics, Inc. - Common Stock?
The ticker symbol for Verve Therapeutics, Inc. - Common Stock is VERV on the Nasdaq Stock Market
What is the current price of Verve Therapeutics, Inc. - Common Stock?
The current price of Verve Therapeutics, Inc. - Common Stock is 11.13
When was Verve Therapeutics, Inc. - Common Stock last traded?
The last trade of Verve Therapeutics, Inc. - Common Stock was at 07/24/25 04:00 PM ET
What is the market capitalization of Verve Therapeutics, Inc. - Common Stock?
The market capitalization of Verve Therapeutics, Inc. - Common Stock is 689.29M
How many shares of Verve Therapeutics, Inc. - Common Stock are outstanding?
Verve Therapeutics, Inc. - Common Stock has 689M shares outstanding.